Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 6
2008 4
2009 2
2010 3
2012 1
2014 2
2015 4
2016 1
2018 3
2019 1
2020 1
2021 2
Text availability
Article attribute
Article type
Publication date

Search Results

29 results
Results by year
Filters applied: . Clear all
Page 1
Mapping phospho-catalytic dependencies of therapy-resistant tumours reveals actionable vulnerabilities.
Coppé JP, Mori M, Pan B, Yau C, Wolf DM, Ruiz-Saenz A, Brunen D, Prahallad A, Cornelissen-Steijger P, Kemper K, Posch C, Wang C, Dreyer CA, Krijgsman O, Lee PRE, Chen Z, Peeper DS, Moasser MM, Bernards R, van 't Veer LJ. Coppé JP, et al. Nat Cell Biol. 2019 Jun;21(6):778-790. doi: 10.1038/s41556-019-0328-z. Epub 2019 Jun 3. Nat Cell Biol. 2019. PMID: 31160710 Free PMC article.
Targeting HER2 by Combination Therapies.
Ruiz-Saenz A, Moasser MM. Ruiz-Saenz A, et al. J Clin Oncol. 2018 Mar 10;36(8):808-811. doi: 10.1200/JCO.2017.77.1899. Epub 2018 Jan 30. J Clin Oncol. 2018. PMID: 29381433 Free PMC article. No abstract available.
HER-2-directed, small-molecule antagonists.
Arkin M, Moasser MM. Arkin M, et al. Curr Opin Investig Drugs. 2008 Dec;9(12):1264-76. Curr Opin Investig Drugs. 2008. PMID: 19037833 Free PMC article. Review.
Two dimensions in targeting HER2.
Moasser MM. Moasser MM. J Clin Oncol. 2014 Jul 1;32(19):2074-7. doi: 10.1200/JCO.2014.55.7652. Epub 2014 May 27. J Clin Oncol. 2014. PMID: 24868026 Free PMC article. No abstract available.
29 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page